Apoptosis inhibitor prevented the decrease of IIL ESP-induced TJs expression and alleviated barrier disruption of Caco-2 monolayer. by Qi Qi Lu (17721401)

“…<p><b>A:</b> Apoptosis inhibitor Z-VAD-FMK pretreatment increased the IIL ESP-decreased TEER. <b>B:</b> Z-VAD-FMK pretreatment reduced the IIL ESP-increased FITC-dextran flux. …”

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Instruments used in the iNPH scale gait domain and the balance domain. by Johanna Rydja (12300797)

Subjects:

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Schematic representation of the main steps from gray images to the corresponding graph of the segmented regions. by Zakaria Belghali (22581967)

Correlations between quantitative gait parameters and functional mobility and iNPH scale scores in the patient group preoperatively. by Johanna Rydja (12300797)

Subjects:

Flow diagram illustrating the sequence of procedures executed during one time step defined as tick, each of which represents one week. by Alexandra M. Campbell (3284094)

Dimensions description and scales used. by Jean-Francois Gehanno (13229260)

AI KRegression by CHIN-CHENG CHU (20718575)

CK8 knockdown and ROCK1 inhibitor suppressed rTsSPc-induced disruption of the Caco-2 monolayer and blocked rTsSPc-promoted IIL invasion. by Wen Wen Zheng (17721404)

Immunofluorescence analysis for F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

Immunofluorescence analysis using dual staining for E-cadherin (E-cad) and afadin and F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

<i>L.</i><i>interrogans</i> induces afadin degradation in infected RPTECs through different strain-dependent mechanisms. by Tetsuya Kakita (4922584)

Proteosomal and pan-caspase inhibitors differentially prevent the disruption of the epithelial cell barrier by the clinical <i>Leptospira</i> isolates. by Tetsuya Kakita (4922584)

Descriptive characteristics for patients and healthy individuals. by Johanna Rydja (12300797)

Subjects:

Functional tests and qualitative gait variables in the patient group, pre- and postoperatively. by Johanna Rydja (12300797)

Subjects:

The RehaGait® system. by Johanna Rydja (12300797)

Subjects:

Flow chart of included patients and dropouts. by Johanna Rydja (12300797)

Subjects:

Dataset of the analyzed data. by Johanna Rydja (12300797)

Subjects:

Quantitative gait variables, comparisons between the patients and the healthy individuals. by Johanna Rydja (12300797)

Subjects: